4//SEC Filing
MIZELL STEVEN 4
Accession 0001127602-24-003099
CIK 0000310158other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:07 PM ET
Size
12.5 KB
Accession
0001127602-24-003099
Insider Transaction Report
Form 4
MIZELL STEVEN
EVP, Human Resources
Transactions
- Exercise/Conversion
Common Stock
2024-02-02$70.71/sh+824$58,265→ 42,143.145 total - Exercise/Conversion
Common Stock
2024-02-02$73.73/sh+32,170$2,371,894→ 74,313.145 total - Sale
Common Stock
2024-02-02$126.65/sh−50,694$6,420,349→ 23,619.145 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-02−824→ 0 totalExercise: $70.71From: 2019-10-30Exp: 2028-10-29→ Common Stock (824 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-02−32,170→ 22,088 totalExercise: $73.73From: 2022-05-04Exp: 2031-05-03→ Common Stock (32,170 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
- [F3]The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001189403
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:07 PM ET
- Size
- 12.5 KB